161 related articles for article (PubMed ID: 29030411)
1. Global shortage of neonatal and paediatric antibiotic trials: rapid review.
Thompson G; Barker CI; Folgori L; Bielicki JA; Bradley JS; Lutsar I; Sharland M
BMJ Open; 2017 Oct; 7(10):e016293. PubMed ID: 29030411
[TBL] [Abstract][Full Text] [Related]
2. Evaluating Safety Reporting in Paediatric Antibiotic Trials, 2000-2016: A Systematic Review and Meta-Analysis.
Pansa P; Hsia Y; Bielicki J; Lutsar I; Walker AS; Sharland M; Folgori L
Drugs; 2018 Feb; 78(2):231-244. PubMed ID: 29218501
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Standardising neonatal and paediatric antibiotic clinical trial design and conduct: the PENTA-ID network view.
Folgori L; Lutsar I; Standing JF; Walker AS; Roilides E; Zaoutis TE; Jafri H; Giaquinto C; Turner MA; Sharland M
BMJ Open; 2019 Dec; 9(12):e032592. PubMed ID: 31892658
[TBL] [Abstract][Full Text] [Related]
5. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials.
Mukattash T; Hawwa AF; Trew K; McElnay JC
Eur J Clin Pharmacol; 2011 May; 67(5):449-61. PubMed ID: 21243345
[TBL] [Abstract][Full Text] [Related]
6. Off-label antibiotic use among paediatric in-patients: a mixed-method prospective study at a tertiary hospital in southwestern Uganda.
Obura B; Alele PE; Obua C
Int J Clin Pharm; 2021 Jun; 43(3):637-644. PubMed ID: 33070297
[TBL] [Abstract][Full Text] [Related]
7. New antibiotics for paediatric use: a review of a decade of regulatory trials submitted to the European Medicines Agency from 2000--why aren't we doing better?
Garazzino S; Lutsar I; Bertaina C; Tovo PA; Sharland M
Int J Antimicrob Agents; 2013 Aug; 42(2):99-118. PubMed ID: 23810180
[TBL] [Abstract][Full Text] [Related]
8. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
[TBL] [Abstract][Full Text] [Related]
9. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
[TBL] [Abstract][Full Text] [Related]
10. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety.
Cuzzolin L; Atzei A; Fanos V
Expert Opin Drug Saf; 2006 Sep; 5(5):703-18. PubMed ID: 16907660
[TBL] [Abstract][Full Text] [Related]
11. Off-label antibiotic use in a specialized children care hospital in Punjab, Pakistan: Findings and implications.
Hafeez M; Saleem Z; Bukhari NA; Hussain K; Shamim R; Hussain A; Bukhari NI
J Infect Dev Ctries; 2020 May; 14(5):540-544. PubMed ID: 32525842
[TBL] [Abstract][Full Text] [Related]
12. Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under.
Onakpoya IJ; Hayward G; Heneghan CJ
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011530. PubMed ID: 26408070
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov.
Stockmann C; Sherwin CM; Ampofo K; Hersh AL; Pavia AT; Byington CL; Ward RM; Spigarelli MG
Int J Antimicrob Agents; 2013 Aug; 42(2):161-6. PubMed ID: 23726436
[TBL] [Abstract][Full Text] [Related]
14. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
[TBL] [Abstract][Full Text] [Related]
15. Why are certain age bands used for children in paediatric studies of medicines?
Hoppu K; Fonseca H
Arch Dis Child; 2021 Jul; 106(7):631-635. PubMed ID: 33419728
[TBL] [Abstract][Full Text] [Related]
16. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.
Lindell-Osuagwu L; Korhonen MJ; Saano S; Helin-Tanninen M; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2009 Jun; 34(3):277-87. PubMed ID: 19650250
[TBL] [Abstract][Full Text] [Related]
17. Off-label antibiotic use in children in three European countries.
Porta A; Esposito S; Menson E; Spyridis N; Tsolia M; Sharland M; Principi N
Eur J Clin Pharmacol; 2010 Sep; 66(9):919-27. PubMed ID: 20532493
[TBL] [Abstract][Full Text] [Related]
18. Clinical setting influences off-label and unlicensed prescribing in a paediatric teaching hospital.
Czarniak P; Bint L; Favié L; Parsons R; Hughes J; Sunderland B
PLoS One; 2015; 10(3):e0120630. PubMed ID: 25756896
[TBL] [Abstract][Full Text] [Related]
19. Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches.
Carnovale C; Conti V; Perrone V; Antoniazzi S; Pozzi M; Merlino L; Venegoni M; Clementi E; Radice S
Eur J Pediatr; 2013 Dec; 172(12):1679-85. PubMed ID: 23913312
[TBL] [Abstract][Full Text] [Related]
20. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
